Cargando…
CD25(high) Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
Regulatory T cells (Treg) impede effective antitumor immunity. However, the role of Tregs in the clinical outcomes of patients with triple-negative breast cancer (TNBC) remains controversial. Here, we found that an immunosuppressive TNBC microenvironment is marked by an imbalance between effector αβ...
Autores principales: | Fattori, Stéphane, Le Roy, Aude, Houacine, Jemila, Robert, Lucie, Abes, Riad, Gorvel, Laurent, Granjeaud, Samuel, Rouvière, Marie-Sarah, Ben Amara, Amira, Boucherit, Nicolas, Tarpin, Carole, Pakradouni, Jihane, Charafe-Jauffret, Emmanuelle, Houvenaeghel, Gilles, Lambaudie, Eric, Bertucci, François, Rochigneux, Philippe, Gonçalves, Anthony, Foussat, Arnaud, Chrétien, Anne-Sophie, Olive, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502453/ https://www.ncbi.nlm.nih.gov/pubmed/37379438 http://dx.doi.org/10.1158/0008-5472.CAN-23-0613 |
Ejemplares similares
-
Quantification of Immune Variables from Liquid Biopsy in Breast Cancer Patients Links Vδ2(+) γδ T Cell Alterations with Lymph Node Invasion
por: Fattori, Stéphane, et al.
Publicado: (2021) -
Endometrial Carcinoma: Immune Microenvironment and Emerging Treatments in Immuno-Oncology
por: Rousset-Rouviere, Sandrine, et al.
Publicado: (2021) -
High-throughput mass cytometry staining for deep phenotyping of human natural killer cells
por: Ben Amara, Amira, et al.
Publicado: (2022) -
Immunohistochemical subtypes predict the clinical outcome in high-risk node-negative breast cancer patients treated with adjuvant FEC regimen: results of a single-center retrospective study
por: Rahal, S., et al.
Publicado: (2015) -
High-dimensional mass cytometry analysis of NK cell alterations in AML identifies a subgroup with adverse clinical outcome
por: Chretien, Anne-Sophie, et al.
Publicado: (2021)